Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 56, 2022 - Issue 2
Journal homepage
1,978
Views
2
CrossRef citations to date
0
Altmetric
Article

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Rolf Gedeborga Department of Surgical Sciences, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8850-7863View further author information
ORCID Icon,
Lars Lindhagenb Uppsala Clinical Research Center (UCR), Uppsala, SwedenView further author information
,
Stacy Loebc Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York, NY, USA;View further author information
,
Johan Styrked Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, SwedenView further author information
,
Hans Garmoa Department of Surgical Sciences, Uppsala University, Uppsala, Sweden;e Translational Oncology and Urology Research (TOUR), King's College London, Guy's Hospital, London, UKView further author information
&
Pär Stattina Department of Surgical Sciences, Uppsala University, Uppsala, SwedenView further author information
Pages 104-111 | Received 05 Oct 2021, Accepted 30 Nov 2021, Published online: 23 Dec 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andreas Josefsson. (2022) Little support for a protective effect of ADT against COVID-19. Scandinavian Journal of Urology 56:2, pages 112-113.
Read now

Articles from other publishers (1)

Karin Welén, Ebba Rosendal, Eva Freyhult, William K. Oh, Magnus Gisslén, Clas Ahlm, Anne-Marie Fors Connolly, Anna K. Överby & Andreas Josefsson. (2022) Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.013. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients. European Urology.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.